April 16, 2026
The Breast Cancer Research Stamp Reauthorization Act of 2026 was recently introduced in both the Senate and the House of Representatives. The bill is led by Senator Jacky Rosen (D-NV), Senator Ashley Moody (R-FL), Representative Beth Van Duyne (R-TX), and Representative Debbie Wasserman Schultz (D-FL). The ACS has long been a key stakeholder in advocacy efforts supporting this legislation.
The Breast Cancer Research Stamp originated with Ernie Bodai, MD, FACS. A breast surgeon, Dr. Bodai partnered with breast cancer survivor Betsy Mullen and advocate David Goodman to lead a grassroots campaign that brought the stamp to life. In 1997, he proposed that the US Postal Service sell a stamp at a slightly higher price, with proceeds supporting breast cancer research. Although the initial proposal was not adopted, Dr. Bodai and a coalition of advocates successfully urged Congress to act. In 1998, a bipartisan group of lawmakers passed the Stamp Out Breast Cancer Act, establishing the program.
“I am beyond pleased that Congress and the ACS are moving forward to extend the Breast Cancer Research Stamp. It is indeed incredible that such a small piece of paper has raised nearly $100 million to advance the treatment of breast cancer over the years,” Dr. Bodai said. “Many of the research projects funded by the stamp have made tremendous contributions in diagnosis and treatment. My hope is that a future project funded through this mechanism may ultimately find a cure.”
The Breast Cancer Research Stamp is a semipostal stamp that supports research conducted by the National Institutes of Health (NIH) and the Congressionally Directed Medical Research Programs. Sold at a price above the standard First-Class rate, it allows the public to directly contribute to breast cancer research. By law, 70% of proceeds support NIH research, while 30% supports Department of Defense research programs.
Since 1998, more than 1.1 billion stamps have been sold, raising nearly $98 million for breast cancer research. The program also has drawn international attention, with several countries pursuing similar initiatives.
“For decades, progress against breast cancer has depended on strong, sustained support for research. The Breast Cancer Research Stamp has empowered Americans to be part of that effort while helping generate critical funding for breast cancer research at the National Institutes of Health and the Department of Defense medical research programs,” said Ronald J. Weigel, MD, PhD, MBA, FACS, Medical Director of ACS Cancer Programs.
“Reauthorizing the stamp preserves a proven tool that raises awareness of breast cancer and helps fuel scientific innovation to improve treatment options and resources for patients, survivors, and those at high risk of the disease,” he added.
This legislation would reauthorize the program for an additional 10 years, through 2037, ensuring continued support for breast cancer research. The ACS also led a coalition letter—signed by 36 organizations—endorsing the legislation.
Contact your legislator to voice your support. In addition, learn more about additional breast cancer–related legislation in an April 2026 Bulletin viewpoint.
Representatives Richard Hudson (R-NC) and Kathy Castor (D-FL), along with 21 other bipartisan members of Congress, recently sent a letter to the Labor, Health and Human Services, and Education Appropriations Subcommittee requesting $11.5 million for the Military and Civilian Partnership for Trauma Readiness Grant Program (MISSION ZERO) in fiscal year (FY) 2027.
MISSION ZERO provides critical funding through the Administration for Strategic Preparedness and Response, which supports the administrative costs of embedding military trauma professionals in civilian trauma centers. These military-civilian trauma care partnerships allow military trauma providers to gain exposure to the treatment of critically injured patients and increase deployment readiness, while advancing trauma care and expanding patient access.
The ACS thanks Congress for providing $4 million for MISSION ZERO for FY 2026 but urges lawmakers to reauthorize and fully fund the program for FY 2027.
Visit SurgeonsVoice and urge your member of Congress to reauthorize MISSION ZERO and support continued funding for this program.
All surgeons interested in taking the next step in their advocacy journey are invited to join the ACS Grassroots Network.
The Grassroots Network will serve as an advocacy forum that elevates the policy priorities of surgeons across specialties and ensures broad representation. As a member, surgeons will:
In addition to federal advocacy, the ACS seeks to understand state-level and practice-specific challenges and opportunities to support advocacy efforts at all levels.
Participation ensures the voice of surgery is represented when it matters most. To join, complete the following survey, and ACS staff will follow up with next steps.
One of the most effective strategies for collaborating with policymakers and their staff is to ensure they hear directly from ACS members during a state advocacy day sponsored by an ACS chapter.
Recently, the ACS New York Chapter and Delaware Chapter each participated in state advocacy days at their respective state capitals, providing ACS Fellows and surgical residents opportunities to engage directly with policymakers and demonstrate the impact of organized medicine.
On March 9–10, members of the New York Chapter of the ACS (NY ACS), in partnership with the Medical Society of the State of New York (MSSNY) and several specialty societies, participated in Advocacy Day at the State Capitol in Albany. Fellows engaged directly with state lawmakers to discuss issues impacting patient care and the practice of medicine.
Participating NY ACS Fellows included (all MD, FACS) Chapter President Anthony J. Vine, Vice-President Art Jenkins, Immediate Past-President Jacob Moalem, Hala Al Asadi, Shani Fruchter, Konstantinos Margetis, Mark Reiner, Steven Burger, Peter Einersen, Art Cooper, Patrick Timmins, and Akshay Kumar.
Advocacy activities began Monday evening with a legislative reception, where Fellows connected with key policymakers, including Assembly Health and Insurance Committee Chairs Amy Paulin and David Weprin, and Senate Health and Insurance Committee Chairs Gustavo Rivera and Jamaal Bailey, along with Senators Michelle Hinchey and Zellnor Myrie. The reception provided an opportunity for informal, productive dialogue.
The following morning featured program remarks and policy briefings led by MSSNY and participating specialty societies. Dr. Vine addressed attendees, emphasizing the importance of a unified voice across The House of Surgery®. NY ACS advocacy efforts focused on concerns regarding Anthem Blue Cross Blue Shield insurance practices and ongoing scope of practice issues in the state. The program also included a health policy panel with legislative leaders and remarks from the New York State Commissioner of Health.
Afternoon legislative meetings were organized by district, allowing Fellows to meet directly with their elected officials. Participants met with Senators Jeremy Cooney, Liz Krueger, Shelley Mayer, Patricia Fahy, and Toby Stavisky, as well as Assembly Members Chris Burdick, Sarah Clark, Jeffrey Dinowitz, John McDonald, and Rebecca Seawright. Fellows shared clinical perspectives and policy priorities, supported by informational materials, including examples of recent legislation from other states.
Throughout the event, NY ACS Fellows reinforced the critical role of physician advocacy in protecting patient access to high-quality care, strengthening the healthcare workforce, and advancing sound health policy.
The chapter extends thanks to executive directors Robin Granger, Donna Gurnett, and Clare Hart for their leadership in coordinating the event, and to MSSNY for its partnership.
On March 26, members of the Delaware Chapter convened at the State Capitol in Dover for Advocacy Day, engaging directly with lawmakers on issues affecting patient care and medical practice.
Delaware Chapter Fellows in attendance included:
Surgical residents Masoom Chainani, MD, Gabriel Nielsen, DO, and Rebecca Schmehl, DO, also participated, alongside Cimone Sylver, PhD, MPA, state government affairs and advocacy manager at ChristianaCare.
The day began with a briefing led by Dr. Ratnasekera and Dr. Costanzo, followed by discussions with key legislative leaders, including Senator Marie Pinkney and House Speaker Melissa Minor-Brown, both of whom have strong healthcare backgrounds.
Surgeons broke into groups to meet with their legislators to advocate on several priority issues, including:
Surgeons also raised broader policy priorities, including expanding Medicaid to protect seniors, families, and rural and community providers; expanding graduate medical education funding, emphasizing that physicians are more likely to practice in the state where they complete residency; and supporting the inclusion of folic acid in cornmeal products as a low-cost, high-impact public health strategy to prevent birth defects in populations where fortified wheat products are not part of traditional diets.
Participants met with multiple legislators, including Representatives Claire Snyder-Hall and Nnamdi Chukwuocha and Senators Spiros Mantzavinos and Russell Huxtable, and received special recognition on the House Floor from Speaker Minor-Brown and on the Senate Floor by Senator Pinkney.
The 2026 Delaware Surgery Advocacy Day provided Fellows and residents with an opportunity to engage policymakers and elevate the voice of surgery in Dover.
The chapter extends thanks to Dr. Sylver for coordinating legislative meetings and recognition events.